Purple amomum (Amomum longiligulare T.L. Wu), which belongs to the monophyletic Zingiberaceae family, is a valuable medicinal plant in Vietnam. The studies on the biological activities of the extracts or essential oils of this species are very limited. So far, there has been no evaluation of the antifungal activity of purple amomum extracts. Fusarium oxysporum Schlecht. and Helminthosporium sativum P. K. & B. fungi which are the causal agent of a wide variety of cereal and many economically important crop species diseases, causing significant losses to agricultural production. The use of plant extracts to control these fungi is an alternative to synthetic fungicides. The attempt of this study was to investigate the antifungal activity of ethanol extracts from different organs of purple amomum against both fungi species. The antifungal effect of purple amomum extracts (including ethanol extract of leaf, seed, rhizome and root, and pseudo-stem) concentrations of 0.05 and 0.10 mg/mL were investigated. Our present study showed that the extracts of purple amomum had different effects on the two fungi species. Extracts of 0.10 mg/mL seed and 0.10 mg/mL leaf in most of the treatments showed the best antifungal effect on both studied fungal species. In all the treatments using seed extract, the lowest indicator of the specific growth rate (m) of the fungi was observed. On the other hand, the antifungal effect of purple amomum extracts on H. sativum fungus appeared to be better than on F. oxysporum fungus. The results of this study open up the prospect of developing new fungicides from purple amomum extracts to treat diseases caused by F. oxysporum and H. sativum fungi in crops.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.